Storys zum Thema Medizin, Gesundheit

STADA Arzneimittel AG

Press release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

OPTIMA packaging group GmbH

5

Reflecting on a successful Pharma Forum 2023

ARTTIC Innovation GmbH

3

EU Provides 1 Mio. to Researchers to Advance Personalised Oncology

ARTTIC Innovation GmbH

canSERV Releases Open Call for Transnational Service Provision

STADA Arzneimittel AG

2

Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals

Terre des Hommes Deutschland e.V.

UN Committee on the Rights of the Child calls on states to take action in first guidance on children's rights and the environment, with a focus on climate change

GENEVA/NEW YORK (ots) - Today, the United Nations Committee on the Rights of the Child published authoritative guidance to States on what they must do to uphold children’s right to a clean, healthy and sustainable environment. In the face of the ...

STADA Arzneimittel AG

2

Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty

Sysmex Europe SE

4

Sysmex Europe SE launches XR-Series, the new flagship product line for laboratory haematology

STADA Arzneimittel AG

Press release : STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi

Aurubis AG

2

Press Release: Aurubis subsidiary RETORTE expanding selenium production for profitable growth markets

STADA Arzneimittel AG

Press release: STADA appoints Christos Gallis as Head of Eastern Europe

ARTTIC Innovation GmbH

Joint Statement: health organisations define EHDS’ opt-out required for life-saving research

Deutsche Post DHL Group

2

PM: „Get Airports Ready for Disaster“-Programm in Sarajevo / PR: Get Airports Ready for Disaster Program held in Sarajevo

Gerresheimer AG

Gerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA

Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...

STADA Arzneimittel AG

Press release: STADA and Xbrane launch ranibizumab to support patient access in Europe

STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...

hubergroup Deutschland GmbH

5

Press Release - hubergroup India expands its support for rural healthcare

STADA Arzneimittel AG

Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022

ARTTIC Innovation GmbH

Free Access to Cancer Research Services - canSERV 1st Call for Proposals

Fördergesellschaft IZB mbH

Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris

Universität Konstanz

Time makes the difference, PI 16/2023

Time makes the difference About 18,000 physicians from Cuba came to Brazil between 2013 and 2018 during the "More Doctors for Brazil" project. The programme aimed at alleviating the public health emergency, however, initially met with surprising resistance, as Konstanz anthropologist Maria Lidola observed in Rio de Janeiro. When countries in the Global ...

STADA Arzneimittel AG

Press release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)

EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...

STADA Arzneimittel AG

Press release: Adalvo and STADA extend their strategic partnership

Adalvo and STADA extend their strategic partnership - Strategic partnership in Europe extended to cover five additional molecules in therapeutic categories including oncology and diabetes - Adalvo CEO Anil Okay: “These new agreements demonstrate the significance of the strategic partnership we have built with STADA, in the last couple of years. We take ...

STADA Arzneimittel AG

Press release: STADA appoints Boris Döbler as Chief Financial Officer

STADA Arzneimittel AG

Press release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe

Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...

Gerresheimer AG

Gerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth

Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...

STADA Arzneimittel AG

3

Press release: STADA starts work on >EUR50m facility to strengthen European medicines supply

STADA Arzneimittel AG

Press release: Stéphane Jacqmin joins STADA from Sanofi and becomes Head of Emerging Markets

hubergroup Deutschland GmbH

5

Press Release - hubergroup India supports rural areas with medical vans

Aurubis AG

6

Press release: Aurubis plants in Hamburg and Lünen receive internationally recognized Copper Mark quality seal

Aurubis AG

3

Press release: Maintenance shutdown at Aurubis plant in Hamburg completed successfully